Literature DB >> 8993953

Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients.

E M de Jong1, B A Seegers, M K Gulinck, J B Boezeman, P C van de Kerkhof.   

Abstract

BACKGROUND AND
OBJECTIVE: Occurrence rates of clinical features of nail psoriasis vary considerably in the literature. Little information is available on subjective complaints of patients affected by psoriasis of the nails.
METHOD: Interviews with 1,728 psoriatic patients concerning their nail changes and complaints are reviewed.
RESULTS: The results indicate that pitting and deformation are the most common clinical aberrations in psoriatic nails, with a positive association between the duration of skin lesions and nail psoriasis. No relation was found between age and nail psoriasis in this group. Remarkably, 51.8% of patients suffered from pain-caused by the nail changes, and a large group of patients was restricted in their daily activities, housekeeping and/or profession (58.9, 56.1, 47.9%). Treatment was disappointing: only 19.3% showed marked improvement during treatment.
CONCLUSION: This indicates that psoriasis of the nails is a more important individual and social-economic problem than previously assumed and that development of new treatments is needed.

Entities:  

Mesh:

Year:  1996        PMID: 8993953     DOI: 10.1159/000246274

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  33 in total

Review 1.  [Nail psoriasis--an ignored disorder. Pathogenesis, diagnosis and therapy].

Authors:  C Kahl; B Hansen; K Reich
Journal:  Hautarzt       Date:  2012-03       Impact factor: 0.751

2.  Early Visible Improvements during K101-03 Treatment: An Open-Label Multicenter Clinical Investigation in Patients with Onychomycosis and/or Nail Psoriasis.

Authors:  Bianca Maria Piraccini; Michela Starace; Anders Toft
Journal:  Dermatology       Date:  2017-08-05       Impact factor: 5.366

3.  Role of HLA-DR Alleles to Increase Genetic Susceptibility to Onychomycosis in Nail Psoriasis.

Authors:  Hilda Carrillo-Meléndrez; Esteban Ortega-Hernández; Julio Granados; Sara Arroyo; Rodrigo Barquera; Roberto Arenas
Journal:  Skin Appendage Disord       Date:  2016-05-13

4.  Prevalence of psoriasis phenotypes among men and women in the USA.

Authors:  J F Merola; T Li; W-Q Li; E Cho; A A Qureshi
Journal:  Clin Exp Dermatol       Date:  2016-02-18       Impact factor: 3.470

5.  Onychodystrophy and its management.

Authors:  Tilmann Oppel; Hans Christian Korting
Journal:  Ger Med Sci       Date:  2003-07-01

6.  Nail psoriasis: clinical presentation and best practice recommendations.

Authors:  Felicity Edwards; David de Berker
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Assessment of nail unit structures by ultrasound in patients with psoriatic arthritis and their correlations with disease activity indices: a case-control study.

Authors:  Sumantro Mondal; Satarupa Dutta; Debasish Lahiri; Debanjali Sinha; Geetabali Sircar; Ashok Kumar Mandal; Megha Kejriwal; Alakendu Ghosh
Journal:  Rheumatol Int       Date:  2018-09-17       Impact factor: 2.631

8.  Short-Term Correlation of the Psoriasis Area Severity Index, the Nail Psoriasis Area Severity Index, and the Dermatology Life Quality Index, before and after Treatment, in Patients with Skin and Nail Psoriasis.

Authors:  Christos Prevezas; Alexander C Katoulis; Evangelia Papadavid; Pantelis Panagakis; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2019-05-21

9.  Nail psoriasis as a severity indicator: results from the PsoReal study.

Authors:  Marc A Radtke; Anna K Langenbruch; Ines Schäfer; Katharina Herberger; Kristian Reich; Matthias Augustin
Journal:  Patient Relat Outcome Meas       Date:  2010-12-22

Review 10.  Challenging regional psoriasis and ustekinumab biotherapy: impact of the patterns of disease.

Authors:  Trinh Hermanns-Lê; Enzo Berardesca; Gérald E Piérard; Marianne Lesuisse; Claudine Piérard-Franchimont
Journal:  J Biomed Biotechnol       Date:  2012-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.